Literature DB >> 32748155

An overview of signaling pathways regulating YAP/TAZ activity.

Boon Chin Heng1,2, Xuehui Zhang3,4, Dominique Aubel5, Yunyang Bai6, Xiaochan Li6, Yan Wei6, Martin Fussenegger7, Xuliang Deng8,9.   

Abstract

YAP and TAZ are ubiquitously expressed homologous proteins originally identified as penultimate effectors of the Hippo signaling pathway, which plays a key role in maintaining mammalian tissue/organ size. Presently, it is known that YAP/TAZ also interact with various non-Hippo signaling pathways, and have diverse roles in multiple biological processes, including cell proliferation, tissue regeneration, cell lineage fate determination, tumorigenesis, and mechanosensing. In this review, we first examine the various microenvironmental cues and signaling pathways that regulate YAP/TAZ activation, through the Hippo and non-Hippo signaling pathways. This is followed by a brief summary of the interactions of YAP/TAZ with TEAD1-4 and a diverse array of other non-TEAD transcription factors. Finally, we offer a critical perspective on how increasing knowledge of the regulatory mechanisms of YAP/TAZ signaling might open the door to novel therapeutic applications in the interrelated fields of biomaterials, tissue engineering, regenerative medicine and synthetic biology.

Entities:  

Keywords:  Hippo; Mechanisms; Regulation; Signaling pathways; TAZ; YAP

Mesh:

Substances:

Year:  2020        PMID: 32748155     DOI: 10.1007/s00018-020-03579-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  115 in total

Review 1.  Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction.

Authors:  Sirio Dupont
Journal:  Exp Cell Res       Date:  2015-10-30       Impact factor: 3.905

2.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

3.  Piezo2 channel regulates RhoA and actin cytoskeleton to promote cell mechanobiological responses.

Authors:  Carlos Pardo-Pastor; Fanny Rubio-Moscardo; Marina Vogel-González; Selma A Serra; Alexandros Afthinos; Sanela Mrkonjic; Olivier Destaing; Juan F Abenza; José M Fernández-Fernández; Xavier Trepat; Corinne Albiges-Rizo; Konstantinos Konstantopoulos; Miguel A Valverde
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

4.  Structural features and ligand binding properties of tandem WW domains from YAP and TAZ, nuclear effectors of the Hippo pathway.

Authors:  Claire Webb; Abhishek Upadhyay; Francesca Giuntini; Ian Eggleston; Makoto Furutani-Seiki; Rieko Ishima; Stefan Bagby
Journal:  Biochemistry       Date:  2011-03-31       Impact factor: 3.162

5.  Molecular pathways: YAP and TAZ take center stage in organ growth and tumorigenesis.

Authors:  Stefano Piccolo; Michelangelo Cordenonsi; Sirio Dupont
Journal:  Clin Cancer Res       Date:  2013-06-24       Impact factor: 12.531

6.  TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins.

Authors:  F Kanai; P A Marignani; D Sarbassova; R Yagi; R A Hall; M Donowitz; A Hisaminato; T Fujiwara; Y Ito; L C Cantley; M B Yaffe
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

Review 7.  Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.

Authors:  Fa-Xing Yu; Bin Zhao; Kun-Liang Guan
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

Review 8.  Regulation of the Hippo Pathway Transcription Factor TEAD.

Authors:  Kimberly C Lin; Hyun Woo Park; Kun-Liang Guan
Journal:  Trends Biochem Sci       Date:  2017-09-27       Impact factor: 13.807

9.  Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor.

Authors:  Murugan Paramasivam; Ali Sarkeshik; John R Yates; Maria J G Fernandes; Dannel McCollum
Journal:  Mol Biol Cell       Date:  2011-08-10       Impact factor: 4.138

10.  YAP regulates cell mechanics by controlling focal adhesion assembly.

Authors:  Giorgia Nardone; Jorge Oliver-De La Cruz; Jan Vrbsky; Cecilia Martini; Jan Pribyl; Petr Skládal; Martin Pešl; Guido Caluori; Stefania Pagliari; Fabiana Martino; Zuzana Maceckova; Marian Hajduch; Andres Sanz-Garcia; Nicola Maria Pugno; Gorazd Bernard Stokin; Giancarlo Forte
Journal:  Nat Commun       Date:  2017-05-15       Impact factor: 14.919

View more
  14 in total

Review 1.  The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms.

Authors:  Yirao Zhang; Yang Wang; Hao Ji; Jie Ding; Keming Wang
Journal:  J Exp Clin Cancer Res       Date:  2022-06-14

Review 2.  Intestinal strictures in Crohn's disease: a 2021 update.

Authors:  Xiaoxuan Lin; Yu Wang; Zishan Liu; Sinan Lin; Jinyu Tan; Jinshen He; Fan Hu; Xiaomin Wu; Subrata Ghosh; Minhu Chen; Fen Liu; Ren Mao
Journal:  Therap Adv Gastroenterol       Date:  2022-06-21       Impact factor: 4.802

3.  CLP36 promotes p53 deficient sarcoma progression through suppression of atrophin-1 interacting protein-4 (AIP-4)-dependent degradation of YAP1.

Authors:  Yixuan Lu; Yongxin Mu; Ju Chen; Xinyuan Guan; Ling Guo; Chuanyue Wu
Journal:  Theranostics       Date:  2022-07-04       Impact factor: 11.600

4.  Sphingolipid Metabolism as a New Predictive Target Correlated with Aging and AD: A Transcriptomic Analysis.

Authors:  Simone D'Angiolini; Luigi Chiricosta; Emanuela Mazzon
Journal:  Medicina (Kaunas)       Date:  2022-03-30       Impact factor: 2.948

Review 5.  Role of YAP1 Signaling in Biliary Development, Repair, and Disease.

Authors:  Laura Molina; Kari Nejak-Bowen; Satdarshan P Monga
Journal:  Semin Liver Dis       Date:  2022-01-24       Impact factor: 6.512

6.  Circular RNA circ‑CCT3 promotes hepatocellular carcinoma progression by regulating the miR‑1287‑5p/TEAD1/PTCH1/LOX axis.

Authors:  Wennan Lin; Tianyu Zhang; Guoxu Ding; Liguo Hao; Bingquan Zhang; Jing Yu; Yu Pang; Feng Geng; Lan Zhan; Minglu Zhou; Qiyu Yan; Yuguang Wang; Chunlei Zheng; Hui Li
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

Review 7.  Signaling pathways and targeted therapy for myocardial infarction.

Authors:  Qing Zhang; Lu Wang; Shiqi Wang; Hongxin Cheng; Lin Xu; Gaiqin Pei; Yang Wang; Chenying Fu; Yangfu Jiang; Chengqi He; Quan Wei
Journal:  Signal Transduct Target Ther       Date:  2022-03-10

8.  KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.

Authors:  Xiaozheng Sun; Pengxiang Chen; Xue Chen; Wenjing Yang; Xuan Chen; Wei Zhou; Di Huang; Yufeng Cheng
Journal:  Thorac Cancer       Date:  2020-12-21       Impact factor: 3.500

9.  Matrix Mechanotransduction via Yes-Associated Protein in Human Lamina Cribrosa Cells in Glaucoma.

Authors:  Rory Murphy; Mustapha Irnaten; Alan Hopkins; Jeffrey O'Callaghan; W Daniel Stamer; Abbot F Clark; Deborah Wallace; Colm J O'Brien
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799

10.  Targeted Quantification of Phosphorylation Sites Identifies STRIPAK-Dependent Phosphorylation of the Hippo Pathway-Related Kinase SmKIN3.

Authors:  Valentina Stein; Bernhard Blank-Landeshammer; Ramona Märker; Albert Sickmann; Ulrich Kück
Journal:  mBio       Date:  2021-05-04       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.